STOCKscreener 
 .  i  n  f  o 
                
clemens: SMI Watchlist
 Login   Help  
 
    
 Home 
 About   News 
 Indices 2017 
 Market News 
 Company News 
 Performance 
 Momentum 
 All Time Highs 
 Trading Systems 
 The STOCK BLOCK 
 Links 
 
 Impressum 
 
 
1. ABB ABBN.VTX
2. ADECCO N ADEN.VTX
3. BALOISE BALN.VTX
4. CIE FINANCIERE RICHEMONT UTS A CFR.VTX
5. CLARIANT CLN.VTX
6. CREDIT SUISSE GRP R CSGN.VTX
7. HOLCIM LTD HOLN.VTX
8. JULIUS BAER N BAER.VTX
9. NESTLE R NESN.VTX
10. NOBEL BIOCARE HOLDING AG NOBN.VTX
11. NOVARTIS R NOVN.VTX
12. ROCHE HOLDING GS ROG.VTX
13. SWATCH B UHR.VTX
14. SWISS LIFE HOLDING SLHN.VTX
15. SWISS RE RUKN.VTX
16. SWISSCOM R SCMN.VTX
17. SYNGENTA SYNN.VTX
18. SYNTHES SYST.VTX
19. UBS R UBSN.VTX
20. ZURICH FINANCIAL SERVICES ZURN.VTX
Time frame , size

ABBN.VTX chartADEN.VTX chart
BALN.VTX chartCFR.VTX chart
CLN.VTX chartCSGN.VTX chart
HOLN.VTX chartBAER.VTX chart
NESN.VTX chartNOBN.VTX chart
NOVN.VTX chartROG.VTX chart
UHR.VTX chartSLHN.VTX chart
RUKN.VTX chartSCMN.VTX chart
SYNN.VTX chartSYST.VTX chart
UBSN.VTX chartZURN.VTX chart

Time frame , size

News

RSS feed
 Novartis AG Novartis drug Afinitor® gains EU approval to treat patients with advanced pancreatic neuroendocrine tumors 2011-09-05 
 Novartis AG Novartis International BioCamp spotlights how diversity spurs innovation across the company and inspires future science leaders 2011-08-29 
 Novartis AG FDA requests additional clinical data on Novartis drug ACZ885 for the treatment of gouty arthritis 2011-08-29 
 UBS AG UBS update on cost reduction plans 2011-08-23 
 UBS AG Oslo, Zurich and Geneva are the most expensive cities in the world. 2011-08-15 
 Nestlé AG First half 2011: solid performance in a volatile environment 2011-08-10 
 ABB Ltd. ABB wins $1 billion order for offshore wind power connection 2011-08-02 
 ABB Ltd. ABB completes acquisition of Mincom 2011-07-29 
 UBS AG UBS second-quarter profit before tax CHF 1.7 billion; Group net new money CHF 8.7 billion; tier 1 capital ratio 18.1% 2011-07-26 
 Novartis AG Novartis drug Afinitor® recommended by CHMP for EU approval to treat patients with advanced pancreatic neuroendocrine tumors 2011-07-22 
 ABB Ltd. ABB second-quarter net income rises 43% amid steady top line growth 2011-07-21 
 ABB Ltd. ABB wins $144 million power orders in Saudi Arabia 2011-07-19 
 Novartis AG Novartis delivers strong financial results and four major approvals in second quarter of 2011 2011-07-19 
 ABB Ltd. ABB wins gas order worth more than $30 million in Abu Dhabi 2011-07-18 
 Novartis AG Novartis begins shipment of Fluvirin® seasonal influenza vaccine to US customers for 2011-2012 influenza season 2011-07-15 
 ABB Ltd. ABB to supply innovative DC power distribution system to green data center 2011-07-13 
 UBS AG UBS to report second quarter 2011 results on 26 July 2011 2011-07-13 
 ABB Ltd. ABB wins $80 million power order for Itaipu hydroelectric plant 2011-07-12 
 ABB Ltd. ABB acquires the Trasfor Group and expands its transformer business 2011-07-11 
 Nestlé AG Nestlé to enter partnership with Chinese confectionery company Hsu Fu Chi 2011-07-11 
 Novartis AG Phase III trial of Novartis drug Afinitor® met primary endpoint of reducing SEGA tumor size in patients with tuberous sclerosis 2011-07-08 
 ABB Ltd. ABB to review preliminary findings in EU Commission’s cables investigation 2011-07-06 
 Novartis AG Novartis drug Afinitor® met primary endpoint of Phase III study in women with advanced breast cancer; potential to address significant unmet need 2011-07-05 
 ABB Ltd. ABB to buy Lorentzen & Wettre to strengthen pulp and paper business 2011-07-04 
 Novartis AG Novartis receives FDA approval for Arcapta(TM) Neohaler(TM), a novel once-daily bronchodilator for chronic obstructive pulmonary disease 2011-07-01 
 Novartis AG Novartis receives approval in Japan for Onbrez® Inhalation Capsules, a novel once-daily bronchodilator therapy for patients with COPD 2011-07-01 
 ABB Ltd. ABB acquires Epyon to expand offering in EV charging infrastructure 2011-07-01 
 UBS AG Axel Weber to be nominated for election to UBS Board of Directors in 2012 and to be appointed Chairman in 2013 2011-07-01 
 Novartis AG Novartis Phase III study shows once-daily NVA237 is superior to placebo and similar to tiotropium in improving lung function in COPD 2011-06-30 
 Novartis AG Novartis drug Votubia® recommended by CHMP for approval in the EU for children and adults with SEGA associated with tuberous sclerosis 2011-06-24 
 Novartis AG FDA panel endorses efficacy but not safety of Novartis drug ACZ885 for gouty arthritis; did not support approval in proposed indication 2011-06-22 
 ABB Ltd. Peter Leupp named non-executive chairman of Gurit Holding 2011-06-20 
 ABB Ltd. ABB wins $42 million power order in Algeria 2011-06-20 
 Novartis AG Novartis begins construction of new state-of-the-art pharmaceutical manufacturing plant in St. Petersburg, Russia 2011-06-16 
 Novartis AG Novartis application for expanded Menveo® indication from 2 months of age accepted for review by FDA 2011-06-16 
 ABB Ltd. ABB wins $85 million order to supply high-voltage power products in Saudi Arabia 2011-06-09 
 Novartis AG Novartis candidate vaccine Bexsero® shows significant potential in providing broad coverage against meningococcal serogroup B infections 2011-06-09 
 Novartis AG Novartis gains European Commission approval for Lucentis® to treat vision loss due to macular edema secondary to RVO 2011-06-06 
 Novartis AG Novartis drug Glivec® shows significant overall survival benefit for patients with GIST after three years of adjuvant treatment vs. one year 2011-06-05 
 Novartis AG Novartis JAK inhibitor INC424 shows significant clinical benefit for myelofibrosis patients in two Phase III studies at ASCO 2011-06-04 
 
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice.
Impressum